BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33517320)

  • 1. BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma.
    Meng X; Matsumoto F; Mori T; Miura N; Ino Y; Onidani K; Kobayashi K; Matsuzaki Y; Yoshimoto S; Ikeda K; Honda K
    Anticancer Res; 2021 Feb; 41(2):1089-1099. PubMed ID: 33517320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
    Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
    Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
    Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
    Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
    Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ
    Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
    Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.
    Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L
    Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
    Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
    Mäkitie AA; Almangush A; Rodrigo JP; Ferlito A; Leivo I
    Head Neck; 2019 Oct; 41(10):3712-3718. PubMed ID: 31328847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
    Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
    J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway.
    Wu J; Chen Z; Zhang L; Cao J; Li X; Gong Z; Bo H; Zhang S; He D
    J Cell Biochem; 2020 Jan; 121(1):867-875. PubMed ID: 31452270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.
    Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL
    Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of Neurotrophin Receptors CD271 and TrkC for Prognosis, Migration, and Proliferation in Head and Neck Squamous Cell Carcinoma.
    Foerster Y; Stöver T; Wagenblast J; Diensthuber M; Balster S; Gabrielpillai J; Petzold H; Geissler C
    Cells; 2019 Sep; 8(10):. PubMed ID: 31569361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma.
    Li H; Yang LL; Wu CC; Xiao Y; Mao L; Chen L; Zhang WF; Sun ZJ
    Am J Clin Pathol; 2020 Apr; 153(5):618-629. PubMed ID: 31977029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.